We develop Software-as-a-Medical-Device (SaMD) AI solutions deployed at the point of care to aid specialists in detecting hard-to-observe tumors. Our technology seamlessly integrates into established diagnostic workflows, with our primary focus being the identification of CIS tumors during Cystoscopy procedures.
